Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124190) titled 'Safety and Efficacy of Subretinal Injection of tPA in Early Submacular Hemorrhage' on May 8.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanxi Aier Eye Hospital
Condition:
Subretinal hemorrhage
Intervention:
Subretinal tPA Injection Cohort:25G vitrectomy combined with subretinal injection of tPA (concentration 10µg/0.1ml) 0.1~0.5 ml, fully covering the hemorrhage area
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2024-04-25
Target Sample Size: Subretinal tPA Injection Cohort:27;
Countries of Recruitment:
China
To know more, visit https...